About HyTest
HyTest is a Healthcare company based in Turku (Finland) founded in 1994, and was acquired by Mindray in May 2021. Immunological reagents are produced for diagnostic and research applications. HyTest offers products and services including Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is HyTest Ltd.
Company details
Founded in 1994 and based in Turku, Finland, HyTest specializes in the development, production, and marketing of immunological reagents, including monoclonal and polyclonal antibodies, sera, plasma, and antigens. These products target areas such as cardiovascular disease, inflammation, infectious diseases, autoimmune diseases, veterinary applications, microbial, and plant toxins. An exclusive agreement has been established with Affinity Life Sciences for assays based on their patented SES-BNP technology to detect proBNP and BNP.
Products & Services of HyTest
HyTest offers a comprehensive portfolio of products and services, including Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products.
Antibodies used for developing laboratory tests worldwide
Components for immunoassay and test development applications
Antibodies for various clinical assay developments
Products supporting blood-related diagnostic tests
Apps and channels of HyTest
its YouTube channel Hytest Ltd has 110 subscribers and 24 videos.
Videos from HyTest
The most watched videos on HyTest's YouTube channel, Hytest Ltd (110 subscribers). Click a video to play it here.
More on Hytest Ltd.
Investors in HyTest
HyTest has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Mindray and Summa Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Summa Equity is focused on thematic and impact investments. | 2016 | summaequity.com | ||
Provider of medical equipment & accessories for both human and veterinary | 1991 | mindray.com | Shenzhen, China |
Investor details for HyTest
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HyTest
3 dated milestones of HyTest across 27 years, from founding to its latest funding, stage changes and deals.
- Founded HyTest is founded.
- Exit Acquired by Summa Equity.
- Exit Acquired by Mindray.
Web traffic of HyTest
The website of HyTest (hytest.fi) receives about 8.2K visits a month.
- Monthly visits8.2K
▼ 19.8% vs previous month
Websites whose visitors overlap most with HyTest. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novusbio.com | 100% | 199.6K | #232,152 | View details | |
proteinbiosystems.com | proteinbiosystems.com | 100% | β | ||
| qedbio.com | 100% | 4.9K | #3,910,628 | View details | |
| rockland-inc.com | 100% | View details | |||
| micropharm.co.uk | 100% | #10,048,263 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 24 similar websites and full traffic analytics for HyTest
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hytest
Complete news archive for HyTest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HyTest
HyTest was founded in 1994.
HyTest is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.
Founded in 1994 and based in Turku, Finland, HyTest specializes in the development, production, and marketing of immunological reagents, including monoclonal and polyclonal antibodies, sera, plasma, and antigens. These products target areas such as cardiovascular disease, inflammation, infectious diseases, autoimmune diseases, veterinary applications, microbial, and plant toxins. An exclusive agreement has been established with Affinity Life Sciences for assays based on their patented SES-BNP technology to detect proBNP and BNP.
HyTest offers Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products.
HyTest has 2 investors. Key investors include Mindray, and Summa Equity.
HyTest operates through Hytest Ltd..
Yes. HyTest was acquired by Mindray in May 2021.

